P

    Personalis Inc (PSNL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.78
    -0.29 (-1.70%)

    Market Cap: $1.82B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(19/29)
    Avg Surprise
    +6.79%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.32 - $-0.23
    6 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.26-3.6%
    60d ago$-0.24+4.6%
    30d ago$-0.24+4.6%
    7d ago$-0.24+3.9%
    Current$-0.25
    Revenue Consensus
    $21M
    Range$21M - $22M
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.29
    Range$-0.43 - $-0.22
    4 analysts
    Revenue Consensus
    $30M
    Range$27M - $32M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.29---
    Sep 26EST
    		-$-0.25---
    Jun 26
    		$-0.30$-0.25-20.00%Miss-30.4%
    Mar 26
    		$-0.29$-0.28-3.57%Miss-61.1%
    Dec 25
    		$-0.26$-0.31+16.13%Beat-13.0%
    Sep 25
    		$-0.24$-0.27+11.11%Beat+62.5%
    Jun 25
    		$-0.23$-0.24+4.17%Beat+4.2%
    Mar 25
    		$-0.18$-0.25+28.00%Beat+30.8%
    Dec 24
    		$-0.23$-0.26+12.88%Beat+57.4%
    Sep 24
    		$-0.64$-0.34-88.24%Miss-33.3%
    Jun 24
    		$-0.24$-0.38+36.84%Beat+52.0%
    Mar 24
    		$-0.26$-0.38+31.58%Beat+57.4%
    Dec 23
    		$-0.54$-0.50-8.00%Miss+19.4%
    Sep 23
    		$-0.48$-0.52+7.69%Beat+17.2%
    Jun 23
    		$-0.50$-0.54+7.41%Beat+16.7%
    Mar 23
    		$-0.61$-0.58-5.17%Miss+3.2%
    Dec 22
    		$-0.67$-0.64-4.69%Miss-48.9%
    Sep 22
    		$-0.58$-0.63+7.94%Beat-45.0%
    Jun 22
    		$-0.60$-0.58-3.45%Miss-76.5%
    Mar 22
    		$-0.63$-0.58-8.62%Miss-117.2%
    Dec 21
    		$-0.45$-0.50+10.00%Beat-32.4%
    Sep 21
    		$-0.40$-0.42+4.76%Beat-48.1%
    Jun 21
    		$-0.34$-0.39+12.82%Beat-17.2%
    Mar 21
    		$-0.29$-0.36+19.44%Beat+0.0%
    Dec 20
    		$-0.34$-0.29-17.24%Miss-750.0%
    Sep 20
    		$-0.27$-0.28+3.57%Beat-58.8%
    Jun 20
    		$-0.29$-0.34+14.71%Beat-52.6%
    Mar 20
    		$-0.29$-0.25-16.00%Miss+58.6%
    Dec 19
    		$-0.04N/A+84.00%Beat-
    Sep 19
    		$-0.17$-0.25+32.00%Beat-
    Jun 19
    		$-0.19$-0.26+26.92%Beat-
    Mar 19
    		$-0.70$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-15.39EV/EBITDA-0.03x
    Price/FCF-17.52xFCF Yield-5.71%
    Profitability
    Profit Margin-153.80%Operating Margin-150.20%
    ROE-50.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-536.72x
    Current Ratio5.28xQuick Ratio5.08x
    Trading Statistics
    Beta2.29Avg Volume3.68M
    52-Week High$18.8952-Week Low$4.67

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.70
    SMA 20$15.32
    SMA 50$14.06
    SMA 200$9.70
    EMA 10$16.49
    EMA 20$15.63
    EMA 50$13.91
    EMA 200$10.24

    MACD

    Line: 1.07Signal: 0.95Hist: 0.12

    ADX

    ADX: 42.8+DI: 34.1-DI: 9.1

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down8.0
    PSAR$18.80

    Bollinger Bands

    Upper Band$18.64
    Lower Band$11.99
    %B Position4338%(Upper)
    Band Width0.72

    RSI (14-Day)

    Neutral
    61.9

    Momentum Oscillators

    Stoch %K61.5
    Stoch %D64.3
    Williams %R-40.5
    ROC (10d)20.8%
    Momentum2.89
    CCI (20d)72.6
    MFI (14d)63.4

    Volatility Measures

    ATR (14d)$0.92(5.5%)
    StdDev (20d)1.66
    Hist Vol78.3%(High)

    Volume Flow

    VWAP$16.88
    OBV89.4M
    AD Line40.3M
    CMF (20d)0.285

    Volume Metrics

    Avg Vol (20d)3.6M
    Vol Ratio0.8x
    VWMA (20d)$16.11

    Pivot Points

    R3$17.98
    R2$17.61
    R1$17.34
    Pivot Point$16.97
    S1$16.70
    S2$16.33
    S3$16.06

    Advanced Oscillators

    TSI28.45
    Ultimate Osc52.5
    KST223.62

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$22.36M$15.47M$17.34M$14.49M$17.20M$20.61M$16.80M$25.71M$22.58M$19.52M$19.68M$18.25M
    Cost of Revenue$17.61M$15.19M$15.45M$12.58M$12.45M$13.40M$12.25M$16.96M$14.54M$14.03M$14.47M$14.77M
    Gross Profit$4.74M$281,000$1.90M$1.91M$4.76M$7.21M$4.55M$8.74M$8.04M$5.49M$5.21M$3.48M
    Operating Expenses$38.33M$32.44M$27.17M$25.20M$26.56M$24.90M$22.66M$23.13M$24.93M$24.37M$29.18M$34.27M
    R&D$16.34M$14.54M$13.07M$12.17M$12.38M$12.64M$11.49M$11.68M$12.96M$12.77M$13.61M$16.74M
    SG&A$22.00M$17.90M$14.09M$13.03M$14.18M$12.26M$11.17M$11.44M$11.97M$11.60M$11.52M$11.97M
    Operating Income$-33,591,000$-32,161,000$-25,266,000$-23,291,000$-21,804,000$-17,696,000$-18,112,000$-14,382,000$-16,893,000$-18,880,000$-23,972,000$-30,793,000
    Interest Income$1.97M$2.17M$1.57M$1.68M$1.88M$2.03M$1.63M$1.38M$1.14M$1.36M$1.48M$1.71M
    Interest Expense$37,000$47,000$65,000$64,000$48,000$28,000$-1,000$7,000$9,000$9,000$9,000$15,000
    Income Before Tax$-31,678,000$-30,016,000$-23,803,000$-21,649,000$-20,054,000$-15,743,000$-16,421,000$-39,086,000$-12,798,000$-12,961,000$-26,579,000$-29,070,000
    Income Tax Expense$5,000$16,000$9,000$3,000$2,000$7,000$4,000$3,000$4,000$7,000$5,000$28,000
    Net Income$-31,683,000$-30,032,000$-23,812,000$-21,652,000$-20,056,000$-15,750,000$-16,425,000$-39,089,000$-12,802,000$-12,968,000$-26,584,000$-29,098,000
    EBITDA$-32,259,000$-30,895,000$-23,691,000$-21,741,000$-20,473,000$-16,239,000$-16,351,000$-38,267,000$-11,663,000$-12,197,000$-25,740,000$-28,662,000
    EBIT$-33,607,000$-32,141,000$-25,308,000$-23,265,000$-21,884,000$-17,742,000$-18,053,000$-40,463,000$-13,925,000$-14,311,000$-28,047,000$-30,761,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PSNL

    Government Contracts

    Gov Obligations (TTM)
    $13.50M
    Gov Obligations / Revenue
    20.9%
    Obligations YoY
    72.3%
    Active Awards
    3
    New Awards (TTM)
    1
    Avg Remaining Term
    1.8 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24E25N0228Department of Veterans AffairsDepartment of Veterans Affairs$13.50MSep 30, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win

    Personalis, Inc. has secured a new task order worth up to US$18.3 million with the U.S. Department of Veterans Affairs’ Million Veteran Program, bringing their total VA MVP task orders to approximately US$243.3 million. While this reinforces Personalis' role in large-scale genomics, the company still faces significant operating losses and high cash burn, with a pending acquisition by Tempus being a key near-term catalyst. Investors should consider these financial challenges despite the expanded VA work.

    Simply Wall Street•8/25/26•
    Somewhat-Bullish

    PSNL Looks 599.0% Overvalued on GF Value™

    Personalis Inc. (PSNL) shares dropped 6% after Craig-Hallum downgraded the stock from buy to hold due to skepticism that a competing bid will exceed Tempus AI’s $16.25 per share offer. Despite recent positive clinical trial data from Moderna, which fueled a stock surge, PSNL trades at a Price-to-Sales ratio of 24.16, significantly higher than its historical median, indicating an extreme overvaluation according to GuruFocus’s GF Value™ metric. The company's GF Score™ reflects moderate overall health, but insider selling suggests caution.

    GuruFocus•8/24/26•
    Bearish

    Tempus AI soars 40% in a week, adding $3.7 billion—over double the Personalis acquisition amount

    Tempus AI (TEM) experienced a significant 40% surge in its stock price this week, adding $3.7 billion to its market capitalization, which is more than double the value of its proposed acquisition of Personalis (PSNL). This increase was driven by encouraging Phase 3 cancer vaccine data from Moderna and Merck, boosting confidence in Tempus's oncology platform. Despite the positive momentum and strong quarterly revenue growth, valuation concerns and analyst divisions remain, with some anticipating a decline from current levels.

    TechStock²•8/23/26•
    Somewhat-Bullish

    Personalis Stock Jumps After Tempus AI Acquisition Deal And Q2 Beat

    Personalis Inc. (PSNL) stock surged 9.41% after announcing an acquisition deal with Tempus AI for $16.25 per share and reporting a strong Q2 revenue beat of $22.4M against a $16.7M consensus. The market is currently pricing PSNL above the offer price, indicating speculation of a higher bid or the value of Tempus stock in the mix. Despite being fundamentally loss-making, the company shows strong unit economics and a solid cash position, supporting the acquisition from a position of strength.

    StocksToTrade•8/23/26•
    Bullish

    Personalis Stock Jumps As Tempus AI Acquisition Reshapes Trade Setup

    Personalis Inc. (PSNL) stock surged by 9.41% due to investor optimism following the announcement of its acquisition by Tempus AI for $16.25 per share. The acquisition price, coupled with strong Q2 revenue of $22.4M and significant growth in its NeXT Personal MRD test clinical volume, has led to a new uptrend for the stock. While the company still faces profitability challenges, the market is now trading PSNL above the deal price, anticipating potential adjustments or competing offers.

    Timothy Sykes•8/23/26•
    Bullish

    Frequently Asked Questions About PSNL

    Does PSNL pay dividends?
    Personalis Inc (PSNL) does not currently pay a regular dividend.
    What is PSNL's market cap?
    Personalis Inc (PSNL) has a market capitalization of $1.82B with a current stock price of $16.78.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In